SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc ($HIMS) is trending after withdrawing its compounded GLP-1 weight-loss pill following FDA warnings and legal pressure, causing a notable stock decline. The community is sharply divided, with bears denouncing the company's practices and forecasting further drops, while bulls perceive the withdrawal as a strategic move to mitigate risk and anticipate a rebound for its broader telehealth platform.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending due to high anticipation for its imminent Q4 earnings report, with the community actively debating its 'undervalued' status and potential for a short squeeze. Investors are optimistic that strong results, backed by its AI-driven lending model, could finally align the stock price with its perceived strong fundamentals.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending as news of an extended $250 million capital runway through 2028 and a new cotton traceability collaboration fuels intense debate among investors. While many anticipate a significant short squeeze given its low float and history of parabolic moves, others express caution over potential dilution and view the rally as speculative.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the inauguration of its Eagle Line pilot production facility, signaling a crucial transition from R&D to scalable manufacturing, which is fueling community speculation about new OEM partnerships and its disruptive potential ahead of upcoming earnings.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is trending due to a mixed financial report, where solid past performance was tempered by a conservative revenue outlook, exacerbating community debate over the company's valuation and the broader SaaS sector's vulnerability to AI advancements. Many investors are weighing whether the stock is an oversold opportunity or if headwinds, including perceived unutilized buybacks, suggest further pressure on the work management software provider.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending after its strategic acquisition of AI vision firm StereoLabs, which the community views as a smart move that expands its unified digital lidar and software platform to offer a complete perception solution for physical AI across diverse applications. This pivotal deal reinforces Ouster's path to profitability and leadership in sectors like robotics, industrial, and smart infrastructure, amidst ongoing discussions about its strong financials and undervalued status.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf (WULF) is trending sharply after Morgan Stanley initiated coverage with a bullish $37 price target, recognizing its strategic expansion into AI/HPC data centers and recent acquisition of new power generation sites. The community is actively discussing WULF's strong infrastructure play and significant partnership with Google, solidifying its position beyond traditional Bitcoin mining amid high AI demand.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending after shareholders approved moving U.S. manufacturing assets to the parent company, a strategic shift expected to significantly leverage IRA tax credits and mitigate geopolitical risks. The community is discussing this as a major catalyst to unlock substantial value, alongside persistent rumors of a multi-billion-dollar sale of its Recurrent Energy unit.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is generating significant conversation following its Q4 '25 earnings, which reported a loss but offered 2026 cost reduction guidance, compounded by intense community speculation surrounding a potential strategic partnership with POSCO. Investors remain sharply divided, with many bullish on high HRC steel prices and expiring unfavorable contracts, while others express skepticism over past performance and recent share dilution in the context of broader US steel tariffs.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals is trending after receiving FDA approval for its RNAi therapeutic, Amvuttra (vutrisiran), to treat ATTR amyloidosis with cardiomyopathy (ATTR-CM), a significant label expansion driving a stock surge and numerous analyst upgrades. The community is actively debating its competitive positioning and potential market share against existing and emerging treatments from rivals like Pfizer and BridgeBio in this rapidly evolving market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Biosig Technologies (NASDAQ:STEX) Major Shareholder Acquires 100,000 Shares of Stock

Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) major shareholder Frank Giustra bought 100,000 shares of the company's stock in a transaction dated Wednesday, February 4th. The stock was...

Biosig Technologies (NASDAQ:STEX) Director Buys $71,910.00 in Stock

Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) Director Morgan Lee Lekstrom acquired 23,500 shares of Biosig Technologies stock in a transaction that occurred on Tuesday, February 3rd. The...

Biosig Technologies (NASDAQ:STEX) Trading Up 7.8% - Here's What Happened

Biosig Technologies (NASDAQ:STEX) Trading 7.8% Higher - Should You Buy...

Biosig Technologies (NASDAQ:STEX) Shares Gap Up Following Insider Buying Activity

Biosig Technologies (NASDAQ:STEX) Shares Gap Up on Insider Buying Activity...

Tuesday 1/27 Insider Buying Report: STEX

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at a recent insider purchase of note. On...

Biosig Technologies (NASDAQ:STEX) Director Morgan Lee Lekstrom Purchases 41,000 Shares of Stock

Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) Director Morgan Lee Lekstrom purchased 41,000 shares of Biosig Technologies stock in a transaction that occurred on Friday, January 23rd. The...

Biosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Buys 51,511 Shares

Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) CIO Mitchell Young Williams bought 51,511 shares of the stock in a transaction on Friday, January 23rd. The shares were bought at an average...

Streamex Buys 9.9% Stake In Empress Royalty

(RTTNews) - Streamex Corp. (STEX) Thursday announced that it has acquired a 9.9% equity interest in Empress Royalty Corp. (EMPR.V) through a strategic share purchase from Terra Capital Natural...

Shares of Streamex (STEX) jumped more than 30% in midday trade on Monday after the company announced plans for a pre-sale of its new gold-backed stablecoin dubbed GLDY.<a href="http://stocktwits.com/symbol/STEX">STEX’s stock</a> was up more than 33% at the time of writing, trading at around $6.98, putting it within reach of its record high of $7.44 recorded in September. Streamex, which went public in May through a reverse merger with BioSig Technologies, has gained more than 60% since its market debut. On Stocktwits, it was among the top trending tickers. Retail sentiment around the company surged to ‘bullish’ from ‘bearish as chatter rose to ‘high’ from ‘extremely low’ levels over the past day.The company stated that GLDY will offer investors a yield of up to 4%, with the pre-sale expected to commence on or before November 10. Streamex described the token as an institutional-grade, physically backed gold asset that combines the stability of traditional gold investments with blockchain-enabled yield and liquidity.According to the company, GLDY aims to provide an alternative to conventional gold exposure products such as exchange-traded funds, which typically carry storage costs and do not generate income. By contrast, GLDY holders will earn a return while maintaining exposure to the gold price.“Over $400 billion sits in traditional gold ETFs, assets that offer price exposure but cost money to hold and provide no yield. GLDY fundamentally changes that,” said Co-Founder and CEO Henry McPhie. “Now, instead of paying to hold gold, investors can get paid to hold gold.”Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bnb-hits-all-time-high-leads-altcoin-rally-after-bitcoin-s-weekend-surge-lifts-crypto-market-to-record/ch6RTHzR3gR">BNB Hits All-Time High, Leads Altcoin Rally After Bitcoin’s Weekend Surge Lifts Crypto Market To Record</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of gold coins. (Photo by Peter M. Fisher/Getty Images)

Streamex Stock Jumps Over 30% On Plans To Launch Gold-Backed Stablecoin GLDY

The company announced that GLDY will offer investors a yield of up to 4%, with the pre-sale expected to commence on or before November 10. 

Equity

Streamex Corp. operates as a Real-World Asset (RWA) tokenization. It engages in the provision of blockchain technology to tokenize physical commodities such as gold and create related financial products. The company was founded by Kenneth L. Londoner, Karl Henry McPhie, and Morgan Lekstrom on February 24, 2009 and is headquartered in Winter Park, FL.

Streamex Corp.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$3.28
Prev Close	$2.99
Open	$3.05
Dividend Yield	0.00%
50-Day Moving Average	$3.61
Beta	1.03
Avg. Volume	1.65M
PE Ratio	-2.34

52-Week High	$14.11
52-Week Low	$0.40
Market Capitalization	$273.96M
EPS (Annual)	-$0.7487
Price to Book	-16.71
Revenue Per Employee	$8,000.00
Enterprise Value/EBITDA	N/A

STEX
Streamex Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest STEX News

STEXStreamex Corp.